CompletedPhase 3

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

516 participantsStarted 2002-03-22

Plain-language summary

To compare the safety and tolerability of etoricoxib and diclofenac sodium in the treatment of osteoarthritis of the knee or hip during a six week period.

Who can participate

Age range40 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient is at least 40 years old and diagnosed with osteoarthritis of the knee or hip * Has a history of treatment with NSAIDs with positive therapeutic benefit * Agree to limit alcohol intake to less than 7 drinks per week and avoid unusual strenuous activity * Females who are able to have children must have negative urine pregnancy tests Exclusion Criteria: * Has rheumatoid arthritis, lupus, Paget's disease affecting the study joint, or Wilson's disease * History of acute ligament or meniscus damage to the study joint (knee or hip) within the past 2 years or arthroscopic surgery on the affected study joint with the past 6 months * Requires joint replacement

What they're measuring

This study will assess the effectiveness of the study drug vs. a comparator to treat successfully OA-related joint pain (judged by WOMAC pain subscale).

Trial details

NCT IDNCT00542087

SponsorOrganon and Co

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2002-12-20

View on ClinicalTrials.gov More Osteoarthritis trials